Showing results (841-850 of 1,396) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|July 17, 2020
CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint BlockadeMichael T Schweizer, Gavin Ha, Roman Gulati, et al.JCO Precision Oncology|April 7, 2023
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical TrialsEnrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, et al.JCO Precision Oncology|April 7, 2023
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR StudyEugene R Ahn, Michael Rothe, Pam K Mangat, et al.JCO Precision Oncology|October 31, 2022
Impact of Clinical Practice Gaps on the Implementation of Personalized Medicine in Advanced Non-Small-Cell Lung CancerHelen Sadik, Daryl Pritchard, Derry-Mae Keeling, et al.JCO Precision Oncology|October 31, 2022
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With ERBB2 Amplification or ERBB2/3 Mutations: Results From the TAPUR StudyRanju Gupta, Funda Meric-Bernstam, Michael Rothe, et al.JCO Precision Oncology|January 13, 2022
Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current PracticeMegan A Czekalski, Rachelle C Huziak, Andrea L Durst, et al.JCO Precision Oncology|January 13, 2022
Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant ChemotherapyGengxi Cai, Zhanwen Guan, Yabin Jin, et al.JCO Precision Oncology|November 4, 2022
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry CompositionElisha Hughes, Susanne Wagner, Dmitry Pruss, et al.JCO Precision Oncology|January 8, 2024
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in TaiwanHsin-Yi Wang, Chao-Chi Ho, Yen-Ting Lin, et al.JCO Precision Oncology|January 18, 2024
Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal CancerOluwadunni E Emiloju, Michael Storandt, Tyler Zemla, et al.Pageof 140